Anodyne

Ibogaine
Ibogaine
Molecular structure via molpic based on CDK
[]
Conformer structure via JSmol
Physical properties
[]
310.4 g/mol [1]
Melting point148 °C [1]
SolubilitySoluble in chloroform [1]
3.9 [1]
Structural Identifiers
[]
C20H26N2[1]
(1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene [1]
CC[C@H]1C[C@@H]2C[C@@H]3[C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC [1]
InChI=1S/C20H26N2O/c1-3-13-8-12-9-17-19-15(6-7-22(11-12)20(13)17)16-10-14(23-2)4-5-18(16)21-19/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3/t12-,13+,17+,20+/m1/s1 [1]
InChIKeyHSIBGVUMFOSJPD-CFDPKNGZSA-N [1]

Ibogaine

Ibogaine (also known as 12-Methoxyibogamine, Endabuse, (-)-Ibogaine, (5β)-12-methoxyibogamine, (18R)-12-methoxyibogamine, 7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido(1',2':1,2)azepino(5,4-b)indole, 12 Methoxyibogamine, 6,9-Methano-5H-pyrido(1',2':1,2)azepino(4,5-b)indole, ibogamine deriv., 6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole, ibogamine deriv. or (1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo(13.3.1.02,10.04,9.013,18)nonadeca-2(10),4(9),5,7-tetraene) is a psychedelic substance of the tryptamine class.

Chemistry

Salts []

Ibogaine is typically found in the form of its hydrochloride salt.

 []

Ibogaine is a absolute mixture

Experience reports []

Legal status []

  • Australia: Ibogaine is a S4 substance.
  • Canada: Ibogaine is a Prescription only substance.[3]
  • New Zealand: Ibogaine is a Prescription only substance.
  • United Kingdom: Ibogaine is a PSA substance.
  • United Nations: Ibogaine is a Unscheduled substance.
  • United States: Ibogaine is a Schedule I under the "Controlled Substances Act (CSA)".

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 197060, Ibogaine. Accessed June 26, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/197060

  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ibogaine. UNII: 3S814I130U. Global Substance Registration System. Accessed June 26, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/3S814I130U

  3. Notice - Prescription Drug List (PDL): Multiple additions. Government of Canada, Health. May 12, 2017. Accessed June 26, 2025. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/pdl-ord/pdl-ldo-noa-ad-2017-05-16-eng.php